- Home
- CVAC vs LENZ Comparison
CVAC vs LENZ Comparison
Compare CVAC & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVAC
- LENZ
- Stock Information
- Founded
- CVAC 2000
- LENZ 2019
- Country
- CVAC Germany
- LENZ United States
- Employees
- CVAC N/A
- LENZ N/A
- Industry
- CVAC Biotechnology: Pharmaceutical Preparations
- LENZ Medicinal Chemicals and Botanical Products
- Sector
- CVAC Health Care
- LENZ Health Care
- Exchange
- CVAC Nasdaq
- LENZ Nasdaq
- Market Cap
- CVAC 1.2B
- LENZ 1.1B
- IPO Year
- CVAC 2020
- LENZ 2021
- Fundamental
- Price
- CVAC $5.35
- LENZ $41.29
- Analyst Decision
- CVAC Hold
- LENZ Strong Buy
- Analyst Count
- CVAC 3
- LENZ 4
- Target Price
- CVAC $6.83
- LENZ $49.75
- AVG Volume (30 Days)
- CVAC 471.1K
- LENZ 415.8K
- Earning Date
- CVAC 11-11-2025
- LENZ 11-05-2025
- Dividend Yield
- CVAC N/A
- LENZ N/A
- EPS Growth
- CVAC N/A
- LENZ N/A
- EPS
- CVAC 1.01
- LENZ N/A
- Revenue
- CVAC $599,540,810.00
- LENZ $5,000,000.00
- Revenue This Year
- CVAC N/A
- LENZ N/A
- Revenue Next Year
- CVAC $23.95
- LENZ $258.37
- P/E Ratio
- CVAC $5.32
- LENZ N/A
- Revenue Growth
- CVAC 675.15
- LENZ N/A
- 52 Week Low
- CVAC $2.37
- LENZ $16.54
- 52 Week High
- CVAC $5.72
- LENZ $42.77
- Technical
- Relative Strength Index (RSI)
- CVAC 44.43
- LENZ 58.81
- Support Level
- CVAC $5.32
- LENZ $39.62
- Resistance Level
- CVAC $5.41
- LENZ $41.80
- Average True Range (ATR)
- CVAC 0.04
- LENZ 2.00
- MACD
- CVAC -0.01
- LENZ -0.11
- Stochastic Oscillator
- CVAC 33.33
- LENZ 75.17
About CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.